Zahravi Pharmacutical Co (XTEH:DZAH1) Interest Expense : IRR Mil (TTM As of . 20)

View and export this data going back to 1990. Start your Free Trial

What is Zahravi Pharmacutical Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Zahravi Pharmacutical Co's interest expense for the six months ended in . 20 was IRR 0.00 Mil. Zahravi Pharmacutical Co does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in . 20.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Zahravi Pharmacutical Co's Operating Income for the six months ended in . 20 was IRR 0.00 Mil. Zahravi Pharmacutical Co's Interest Expense for the six months ended in . 20 was IRR 0.00 Mil. Zahravi Pharmacutical Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Zahravi Pharmacutical Co Interest Expense Historical Data

The historical data trend for Zahravi Pharmacutical Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zahravi Pharmacutical Co Interest Expense Chart

Zahravi Pharmacutical Co Annual Data

Trend

Interest Expense

Zahravi Pharmacutical Co Semi-Annual Data

Interest Expense

Zahravi Pharmacutical Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Zahravi Pharmacutical Co (XTEH:DZAH1) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Zahravi Pharmacutical Co's Interest Expense for the six months ended in . 20 was IRR0.00 Mil. Its Operating Income for the six months ended in . 20 was IRR0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in . 20 was IRR0.00 Mil.

Zahravi Pharmacutical Co's Interest Coverage for the quarter that ended in . 20 is calculated as

Zahravi Pharmacutical Co had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Zahravi Pharmacutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zahravi Pharmacutical Co (XTEH:DZAH1) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

18th km of Karaj Special Road, Darupakhsh Street, Darupakhsh Factories, Entrance No. 2, No. 23, Tehran, IRN

Website

http://www.zahravi.com

Zahravi Pharmacutical Co is engaged in the pharmaceutical sector. It produces various tablets, capsules, injections, and soft gel capsules. Some of its products are Cograft, Iminoral, Clexaparin, Roaccutane, and others.

Zahravi Pharmacutical Co Headlines

No Headlines